DIMENSIONAL FUND ADVISORS LP

Position in ELDN — Eledon Pharmaceuticals, Inc.

CIK 354204 AUSTIN, TX

Position in ELDN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$2,122,625

+$1,916,016 QoQ

Shares Held

538,738

+703.1% QoQ

Ownership

0.663%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#23

of 159 holders

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 84% Shared 13% None 3%

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $6,105,781,868 across 230 Biotechnology names. ELDN ranks #135 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,168,956	$580,655,511
2	JAZZ	Jazz Pharmaceuticals plc	1,713,592	$412,924,262
3	REGN	Regeneron Pharmaceuticals, Inc.	559,687	$348,987,230
4	INCY	Incyte Corp	2,280,803	$258,551,825
5	EXEL	Exelixis, Inc.	4,426,620	$240,852,392
6	BMRN	Biomarin Pharmaceutical Inc	4,075,714	$233,212,353
7	ROIV	Roivant Sciences Ltd.	5,230,417	$185,104,455
8	KRYS	Krystal Biotech, Inc.	476,038	$176,929,041

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,122,625	538,738	+703.1%	Shares	Sole	2026-08-11
2026-03-31	$206,609	67,081	-42.0%	Shares	Sole	2026-05-07
2025-12-31	$174,678	115,682	-14.2%	Shares	Sole	2026-02-12
2025-09-30	$349,029	134,761	-1.2%	Shares	Sole	2025-11-12
2025-06-30	$369,793	136,456	+17.5%	Shares	Sole	2025-08-12
2025-03-31	$393,831	116,175	+404.4%	Shares	Sole	2025-05-13
2024-12-31	$94,895	23,033	-32.7%	Shares	Sole	2025-02-13
2024-09-30	$85,215	34,223	+13.2%	Shares	Sole	2024-11-07
2024-06-30	$79,814	30,233	+68.4%	Shares	Sole	2024-08-09
2023-03-31	$42,371	17,954	0.0%	Shares	Sole	2023-05-12
2022-12-31	$40,935	17,954	+0.0%	Shares	Sole	2023-02-09
2022-09-30	$49,542	17,950	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.